On this question of concern to people in Taiwan, Chen says that while 15 years ago it might have been impossible, Taiwan now possesses sufficient sophistication in the biomedical field to develop new drugs. However, the key is that there is a long road that must be traversed from successful development to introduction on the mass market. So unless a total commitment exists, the effort is wasted.
針對這個國人關心的問題，陳垣崇表示，15 年前或許不可能，但如今台灣的生醫水準已經具備研發新藥的能力，關鍵是，從研發成功到量產上市，仍有漫長而艱困的路要走，若不能堅持到底也是枉然。